Hostname: page-component-745bb68f8f-v2bm5 Total loading time: 0 Render date: 2025-01-15T11:14:39.609Z Has data issue: false hasContentIssue false
  • English
  • Français

Safety of 5–HT reuptake inhibitors

Published online by Cambridge University Press:  02 January 2018

Debbie Harrison
Debbie Harrison*
Affiliation:
Lilly Industries Ltd, Dextra Court, Chapel Hill, Basingstoke, Hampshire RG21 2SY
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
The British Journal of Psychiatry , Volume 160 , Issue 6 , June 1992 , pp. 866
Copyright
Copyright © The Royal College of Psychiatrists 

References

Pinder, R. M. (1988) The risks and benefits of antidepressant drugs. Human Psychopharmacology, 3, 73–86.CrossRefGoogle Scholar
Committee on Safety of Medicines (1985) CSM Update. British Medical Journal, 291, 1638.CrossRefGoogle Scholar
Cassidy, S. & Henry, J. (1987) Fatal toxicity of antidepressant drugs in overdose. British Medical Journal, 295, 1021–1025.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.